 | 01/27/2010 | Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk - (Br J Haematol) |
| 01/26/2010 | Analysis of von Willebrand Factor Multimers by Simultaneous High- and Low-Resolution Vertical SDS-Agarose Gel Electrophoresis and Cy5-Labeled Antibody High-Sensitivity Fluorescence Detection - (Am J Clin Pathol) |
| 01/19/2010 | The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo - (Transfusion) |
| 01/13/2010 | FDA Approves Plasma Replacement Therapy for von Willebrand Disease - (DGNews) |
| 01/11/2010 | Pathophysiology of thrombotic thrombocytopenic purpura - (Int J Hematol) |
| 01/11/2010 | Thrombotic thrombocytopenic purpura: recognition and management - (Int J Hematol) |
| 01/08/2010 | Pivotal role of ADAMTS13 function in liver diseases - (Int J Hematol) |
| 01/05/2010 | Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction - (Ann Med) |
| 12/28/2009 | An autoantibody epitope comprising residues R660, Y661 and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF - (Blood) |
| 12/21/2009 | Von Willebrand disease : Diagnosis and management - (Internist (Berl)) |
| 12/16/2009 | Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies - (Bailliere's Best Practice and Research in Clinical Haematology) |
| 12/16/2009 | Diagnosis of platelet-type von Willebrand disease by flow cytometry - (Haematologica) |
| 12/16/2009 | Pregnancy and delivery in women with von Willebrand disease and different von willebrand factor mutations - (Haematologica) |
| 12/15/2009 | The role of prophylaxis in the management of von Willebrand disease: today and tomorrow - (Thromb Res) |
| 12/15/2009 | Classification of inherited von Willebrand disease and implications in clinical practice - (Thromb Res) |
| 12/08/2009 | Impact of Thrombogenic Mutations on Clinical Phenotypes of von Willebrand Disease - (Clin Appl Thromb Hemost) |
| 11/30/2009 | Notes on laboratory coagulation testing for acquired hemophilia A - (Jpn J Clin Pathol) |
| 10/22/2009 | Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor - (Bipolar Disord) |
| 10/21/2009 | Positive Long-Term Effects of Metformin on Endothelial Function and Inflammation in People With Type 2 Diabetes Treated With Insulin: Presented at IDF - (DGDispatch) |
| 10/21/2009 | TopAbstracts in Hypertension 10/21/2009 - (DGNews) |
| 10/19/2009 | Haemorrhagic transformation of cerebral infarction in an AIDS patient - thrombophaelia screen essential! - (Int J STD AIDS) |
| 10/18/2009 | Postoperative Anticoagulation Therapy Necessary in Patients Following Major Surgery: Presented at ASA - (DGDispatch) |
| 10/16/2009 | Effects of Atenolol or Losartan on Fibrinolysis and von Willebrand Factor in Hypertensive Patients With Left Ventricular Hypertrophy - (Clin Appl Thromb Hemost) |
| 10/09/2009 | ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus - (Blood Coagul Fibrinolysis) |
| 10/07/2009 | Metformin Improves Endothelial Function in Type 2 Diabetes: Presented at EASD - (DGDispatch) |
| 09/22/2009 | Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women - (Haemophilia) |
| 09/14/2009 | Molecular and phenotypic determinants of response to desmopressin in adult patients with mild hemophilia A - (J Thromb Haemost) |
| 09/10/2009 | Baseline von Willebrand factor plasma levels and no-reflow phenomenon after primary percutaneous coronary intervention for ST segment elevation myocardial infarction - (Int J Cardiol) |
| 09/03/2009 | Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy--The Stockholm Heart Epidemiology Program - (Brain) |
| 08/28/2009 | Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men - (Blood) |
| 08/26/2009 | Von Willebrand disease: key points from the 2008 national heart, lung, and blood institute guidelines - (Obstetr Gynecol) |
| 08/11/2009 | Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction - (J Thromb Thrombol) |
| 07/21/2009 | Migraine and Biomarkers of Endothelial Activation in Young Women - (Stroke) |
| 07/14/2009 | Effect of blood group on idiopathic thrombotic thrombocytopenic purpura - (J Clin Apheresis) |
| 07/07/2009 | Undetected factor VIII in a patient with type 3 von Willebrands disease mistaken as severe haemophilia A - (Haemophilia) |
| 07/06/2009 | Expression of fourteen von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study - (J Thromb Haemost) |
| 07/03/2009 | The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission - (J Thromb Haemost) |
| 07/03/2009 | Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality - (Intensive Care Med) |
| 06/12/2009 | Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II) - (J Am Coll Cardiol) |
| 06/11/2009 | Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene - (Acta Haematol) |
| 06/11/2009 | Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio - (Acta Haematol) |
| 06/11/2009 | Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains - (Acta Haematol) |
| 06/11/2009 | Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings - (Acta Haematol) |
| 06/11/2009 | Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies - (Acta Haematol) |
| 06/11/2009 | Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions - (Acta Haematol) |
| 06/11/2009 | Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 families - (Acta Haematol) |
| 06/11/2009 | C1584: effect on von Willebrand factor proteolysis and von Willebrand factor antigen levels - (Acta Haematol) |
| 06/11/2009 | Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1 - (Acta Haematol) |
| 06/11/2009 | Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1 - (Acta Haematol) |
| 06/11/2009 | Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management - (Acta Haematol) |